Progress Report March 2016

Similar documents
National Xpert MTB/RIF Programme

Progress Report July 2014

SOUTH AFRICA S TB BURDEN - OVERVIEW

TB in the Southern African mining sector and across the sub-region STOP TB Partnership Board Meeting By Dr Aaron Motsoaledi Minister of Health South

National Institute for Communicable Diseases -- Weekly Surveillance Report --

KidzAlive Model: Best practice in providing holistic HIV testing, disclosure, care and support for children and their families.

How best to structure a laboratory network with new technologies

Lessons learnt from Xpert implementation and holistic solutions required for the successful scale-up of Omni

Strengthening comprehensive post-rape care services in South Africa - Lessons learnt in achieving scale and planning for sustainability

South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018

South Africa Country Report FY14

Ministry of Health. National Tuberculosis Control Program INTEGRATED TB HIV PROGRAM REPORT (JANUARY JUNE 2015)

Quality Improvement of HIV and AIDS programs: experiences from South Africa ( )

Overview November 2017

Integrated VL/EID& TB Data Review Meeting 23/3/2018 PIATO

Situation Report. 1. Highlights. 2. Background. 3. Emergency Management Approach. Team A prior to a factory inspection in Bloemfontein, 6 June 2018.

Health Care Worker Training on Roll Out New TB Diagnostic Test. Prepared by: City Health (J Caldwell) & NHLS (M Bosman & I Noordien)

The Lancet Infectious Diseases

- UPDATE - Implementation and roll-out of Xpert MTB/RIF October 2011

COMMUNITY SYSTEMS TOOLBOX COMMUNITY SYSTEMS STRENGTHENING. Increasing access to quality health and social services. Building strong communities.

MDR, XDR and Untreatable Tuberculosis and Laboratory Perspectives. Martie van der Walt TUBERCULOSIS EPIDEMIOLOGY & INTERVENTION RESEARCH UNIT

DEPARTMENT OF HEALTH RESPONSE TO KEY POPULATIONS

FGSZ Zrt. from 28 February 2019 till 29 February 2020 AUCTION CALENDAR: YEARLY YEARLY BUNDLED AT CROSS BORDER POINTS

: uptake and impact of Xpert MTB/RIF

Situation Report. 1. Highlights. 2. Background. 3. Emergency Management Approach

Diagnosing Xpert MTB/RIF negative TB suspects: Impact and cost of an alternative algorithm

Evolution of XDR-TB. A. Willem Sturm Interim Director K-RITH Nelson R Mandela School of Medicine University of KwaZulu-Natal

DST for detection of DR TB - roll out of Xpert in South Africa and overview of other technologies: what are the gaps?

Quality improvement of the viral load programme in Mopani District, Limpopo Province

Situation Report. 1. Highlights. 2. Background. 3. Emergency Management Approach

POSITIONING OF TB DX : TIERED SYSTEM, INTEGRATED APPROACH

1. Highlights. 2. Background. 3. Emergency Management Approach

HIV Clinicians Society Conference TB/HIV Treatment Cascade

Situation Report. 1. Highlights

Situation Report. 1. Highlights. 2. Background

Dr Richard Christopher,(Pediatrician) Ministry of Health and Social Welfare NTLP- TANZANIA Tanzania. Childhood TB Roadmap Paris 0ctober 29

Experience with implementation of Xpert MTB/RIF in India. Dr K S Sachdeva Addl. DDG (TB), Government of India

IHI South Africa Quarterly Report

GeneXpert (Xpert MTB/RIF): what is the future?

Xpert MTB/RIF assay validation experience --- impact and plan in China

Ethiopia. Targeted Tuberculosis Case Finding Interventions in Six Mining Shafts in Remote Districts of Oromia Region in Ethiopia PROJECT CONTEXT

Xpert MTB/RIF Ultra: Understanding this new diagnostic and who will have access to it

FAST pilot to scale-up: Lessons learnt from Nigeria

The Health Economics and Epidemiology Research Office (HE 2 RO): An overview of research methods and results

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

CASE STUDY Improving the quality of VMMC services at Mangochi, Mzimba North, and Nkhotakota District Hospitals in Malawi

Implementation and scale-up of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB. Global Consultation

Drug resistance surveillance: progress to date and emerging innovations

TB Outbreak in a Homeless Shelter

Sleep Market Panel. Results for June 2015

Naseem Cassim, Lindi M. Coetzee, Keshendree Moodley, Kathryn Schnippel, Nelesh P. Govender and Deborah K. Glencross

Intensified TB Case Finding using a TB screening tool integrated into an HIV clinical record: Experiences from the Eastern Cape Province

AFB Identification Texas Approach

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

FFT and Patient Insight for Improvement. Marie Allen Head of Service User and Carer Experience

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Global Fund Approach to Health System Strengthening

Treatment of Extensively Drug Resistant Tuberculosis Among Patients with HIV Infection in South Africa

THE BURDEN OF HEALTH AND DISEASE IN SOUTH AFRICA

TB FIT Modelling. 24th Annual PhilCAT Convention. Ivor Langley and Ewan Tomeny Liverpool School of Tropical Medicine AUGUST 2017

Press Release. Date: 24 March Re: Launch of the Online TB Surveillance Dashboard

Assessing the programmatic management of drug-resistant TB

Soedarsono Department of Pulmonology & Respiratory Medicine Faculty of Medicine, Universitas Airlangga Dr. Soetomo General Hospital

ASSESSMENT OF GENE-XPERT MTB RIF PROGRAM IMPLEMENTATION AND THE CHALLENGES FOR ENHANCED TUBERCULOSIS DIAGNOSIS IN NIGERIA

HIV&AIDS, STI and TB Workplace Response Public Sector Work Place HIV&AIDS STI Response

Situation Report. 1. Highlights. 2. Background

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME

Challenges in Capacity in SA for diagnosing DR-TB

Early Infant Diagnosis-Malawi Experience. P.N.Kazembe

9 Tuberculosis. Introduction. Lieve Vanleeuw and Marian Loveday

Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB

Xpert MTB/Rif What place for TB diagnosis in MSF projects? Francis Varaine, MSF Geneva, 29/11/10

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Kristina Wallengren, PhD MPH

Xpert MTB/RIF test Rollout and Implementation Plan

Definitions and reporting framework for tuberculosis 2013 revision. Dennis Falzon Global Forum of Xpert MTB/RIF Implementers Annecy 17 April 2013

Index. Research Objective. Health Issues in SA Non-communicable diseases Diabetes Cancer Hypertension. Communicable Diseases HIV AIDS TB

Xpert MTB/RIF use for TB diagnosis in TB suspects with no significant risk of drug resistance or HIV infection. Results of Group Work

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43

Current status of implementation and monitoring and evaluation of collaborative TB/HIV activities. Avinash Kanchar

The Role of the Responsible Pharmacist (RP)

When good genes go bad

IPT Policy Review South Africa. WHO TB/HIV Working Group meeting

Liberia Ebola Daily Sitrep no. 232 for 2 nd January 2015

Receipt within 1 day of specimen collection. Report AFB b smear result within 1 day from receipt of specimen

Parallel Session: 7th SA Aids Conference. 9 June 2015 Address by: Dr SM Dhlomo

New frontiers: Innovation and Access

Epidemiology and diagnosis of MDR-TB in children H Simon Schaaf

South West Cancer Alliances Rapid Diagnostic Pathway for Lung Cancer Project Evaluation

STRENGTHENING THE COORDINATION, DELIVERY AND MONITORING OF HIV AND AIDS SERVICES IN MALAWI THROUGH FAITH-BASED INSTITUTIONS.

Quality improvement efforts in Nigerian public health facilities

LIMPOPO PROVINCIAL MEN S SECTORS/BROTHERS FOR LIFE

The innovation gaps and challenges for MDR-TB. Blessina Kumar TB/ HIV Activist Community Representative & Vice Chair STBP Coordinating Board

INFLUENZA IN MANITOBA 2010/2011 SEASON. Cases reported up to January 29, 2011

Breast Test Wales Screening Division Public Health Wales

INFLUENZA IN MANITOBA 2010/2011 SEASON. Cases reported up to October 9, 2010

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Parity: Innovation in Practice

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

Transcription:

Progress Report March 2016

Table of Contents Background to project 3 Assays performed to date 3 Correctional Services 5 Peri-Mining 6 Rif Concordance 7 Training: Laboratory and Clinical 7 Challenges identified during the course of the project to date 8 Upcoming Plans 8 2 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

1. Background to Project This project was initiated at the request of the Honorable Minister of Health, Dr Aaron Motsoaledi, in early 2011, following the World Health Organization s strong recommendation published in December 2010 which stated that the new automated DNA test for TB be used as the initial diagnostic test in individuals suspected of MDR TB or HIV/TB. In essence this comprises the majority of those with presumptive TB in South Africa. The programme was further expanded to directly support the screening for TB and HIV in high risk populations in correctional centres and in peri-mining communities. GeneXpert Placements Figure 1: Current GeneXpert Placements (211 testing centers, 314 analysers, GX4: 115; GX16-8: 1; GX16: 189; GX48:1; GX80: 8) 2. Assays performed to date In summary, a total of 8,185,277 specimens have been processed to date (31 March 2016). In March 2016, a total 200,034 specimens were processed. The total % of Mycobacterium tuberculosis complex (MTBC) detected in this cohort was 8.71% (17 426). 3 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

Table 1: National GeneXpert MTB Results (Cumulative) Year MTB MTB Not Test Unsuccessful Total % MTB 2011 34,421 165,582 5,441 205,444 16.75 2012 93,248 544,109 16,903 654,260 14.25 2013 201,681 1,478,260 51,773 1,731,714 11.65 2014 249,014 2,060,754 62,038 2,371,806 10.50 2015 245,912 2,343,453 57,193 2,646,558 9.29 2016 55,814 505,184 14,497 575,495 9.70 TOTAL 880,090 7,097,342 207,845 8,185,277 10.75 Table 2: National GeneXpert RIF Results (Cumulative) Year Inconclusive Resistant Sensitive No RIF Result Total % RIF Resistant 2011 311 5,634 28,171 305 34,421 16.37 2012 1,288 7,809 83,321 830 93,248 8.37 2013 5,122 13,451 182,015 1,093 201,681 6.67 2014 6,068 16,312 226,254 380 249,014 6.55 2015 3286 15042 227357 227 245,912 6.12 2016 585 3425 51756 48 55,814 6.14 Total 16,660 61,673 798,874 2,883 880,090 7.01 Figure 2: MTB Positivity and RIF Resistant rates overtime 30.00 National GeneXpert MTB results 25.00 20.00 15.00 %MTB %RIF Resistance 10.00 5.00 0.00 3 4 5 6 7 8 9 101112 1 2 3 4 5 6 7 8 9 101112 1 2 3 4 5 6 7 8 9 101112 1 2 3 4 5 6 7 8 9 101112 1 2 3 4 5 6 7 8 9 101112 1 2 3 2011 2012 2013 2014 2015 2016 4 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

No. of Tests Figure 3: GeneXpert Monthly Uptake Monthly Uptake 300000 250000 200000 2011 2012 150000 2013 2014 100000 2015 2016 50000 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Decrease in number of tests reported for the month of March 2016 compared to March 2015 due to the Easter Holidays falling in the month of March instead of the usual April month. 3. Correctional Services In order to improve TB control in all 242 correctional facilities in South Africa, the NHLS is working in partnership with the Department of Correctional Services (DCS), NDoH, Aurum Institute, TB/HIV Care Association and Right to Care to ensure access to regular HIV- and TB-related screening, testing and treatment of up to 150,000 offenders through the Global Fund programme. Xpert MTB/Rif testing is being provided at either one of the 7 on-site labs, or at the nearest NHLS referral laboratory. Total of 225,127 specimens have been processed to date (31 March 2016). The total % of Mycobacterium tuberculosis complex (MTBC) detected in this cohort was 4.46% (10,044). Table 3: Correctional Service GeneXpert MTB Results (Cumulative) Year MTB MTB Not Test Unsuccessful Total % MTB Oct- Dec 2013 662 7,236 142 8,040 8.23 5 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

Jan- Dec 2014 3,620 55,995 1,004 60,619 5.97 Jan- Dec 2015 4,831 124,589 2,216 131,636 3.67 Jan -Mar 2016 931 23,369 532 24,832 3.75 Total 10,044 211,189 3,894 225,127 4.46 Table 4: Correctional Service GeneXpert RIF Results (Cumulative) Year Resistant Inconclusive Sensitive No RIF Result Total % RIF Resistant Oct- Dec 2013 27 7 626 2 662 4.08 Jan - Dec 2014 188 107 3,323 2 3620 5.19 Jan - Dec 2015 190 99 4,530 12 4831 3.93 Jan -Mar 2016 34 10 887 0 931 3.65 Total 439 223 9,366 16 10,044 4.37 4. Peri-Mining Communities NHLS, together with the Aurum Institute, has been appointed by NDoH (under the Global Fund grant) to provide services to implement interventions aimed at improving TB and HIV/AIDS management for vulnerable peri-mining communities (estimated at around 600,000 people) in 6 main mining districts. Six staffed and GeneXpert-equipped mobile TB units undertake Xpert MTB/RIF testing for TB in these communities. A total of 48,756 specimens have been processed to date (31 March 2016). The total % of Mycobacterium tuberculosis complex (MTBC) detected in this cohort was 1.08% (528). Table 5: Peri-mining GeneXpert MTB Results (Cumulative) Year MTB MTB Not Test Unsuccessful Grand Total % MTB Jun to Dec 2014 56 2410 66 2531 2.17 Jan to Dec 2015 405 37021 609 38036 1.07 Jan to Mar 2016 67 7,935 187 8189 0.82 Total 528 47366 862 48756 1.08 Table 6: Peri-mining GeneXpert RIF Results (Cumulative) Year Inconclusive Resistant Sensitive No Results Total % Resistant Jun to Dec 2014 3 2 51 0 56 3.57 Jan to Dec 2015 10 27 364 4 405 6.67 6 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

Jan to Mar 2016 1 3 57 6 67 4.48 Total 14 32 472 10 528 6.06 5. mhealth and Linkage-to-Care Programme for MDR-TB Emocha (now called milinc) In 2015 a milinc application was launched in South Africa to link thousands of patients afflicted with multi-drug resistant tuberculosis (MDR-TB) to specialised clinics for Care. As of 31 March 2016, milinc has screened over 7668 patients at 18 facilities. milinc has linked 35/56 Rif Resistant patients into care in an average of 3 days and 8 hours. Table 7: Summary from milinc Dashboard (March 2015 to 10 February 2016) *Provinces initiated KZN, EC Number of facilities initiated 28 Number of patients screened 8607 Rifampicin Resistant (R-R) 58(1%) TB sensitive 10% TB Negative 78% R-R patients linked to care 35 Average time linked to care 3 days, 8 hours Dashboard is currently only reporting on 18 facilities. The dashboard is still under construction. *Not all districts initiated. 7 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

6. RIF Concordance A total of 45,486 Rif Resistant cases were reported between 1 March 2011 and 30 September 2015 by GeneXpert testing, 48% had a follow up confirmatory tests performed by either culture or LPA, of those there was a concordance of 86% for RIF resistance between GX and MGIT and 88% between GeneXpert and LPA. Table 7: Rif Concordance by LPA or DST (from March 2011 to 30 September 2015) Province Rif Resistant Cases GeneXpert Confirmation & Rif Concordance MGIT LPA Rif Confirmed Preanalytical/No Concordance Rif Confirmed Concordance # % # % result # % # % Indeterminate Eastern Cape 8,663 348 4.0% 233 67.0% 3 2,823 32.6% 2,612 92.5% 11 Free State 2,701 217 8.0% 120 55.3% 0 852 31.5% 699 82.0% 187 Gauteng 6,297 219 3.5% 146 66.7% 4 1,604 25.5% 1,437 89.6% 29 Kwazulu- Natal 13,869 3,737 26.9% 3473 92.9% 0 3,630 26.2% 3,252 89.6% 166 Limpopo 2,101 94 4.5% 71 75.5% 2 508 24.2% 406 79.9% 21 Mpumalanga 3,333 679 20.4% 667 98.2% 0 1,258 37.7% 1,079 85.8% 3 North West 2,397 203 8.5% 139 68.5% 0 769 32.1% 621 80.8% 52 Northern Cape 1,341 283 21.1% 215 76.0% 3 566 42.2% 432 76.3% 34 Western Cape 4,784 185 3.9% 64 0.0% 0 3,753 78.4% 3,470 92.5% 3 National 45,486 5,965 13.1% 5,128 86.0% 12 15,763 34.7% 14,008 88.9% 506 *table generated quarterly in order match GX RESULTS with follow up confirmatory tests 7. Training: Laboratory and Clinical A total of 2,084 laboratory staff and 10,447 health care workers have been trained since December 2011. This will be an ongoing process to support NDoH training on clinical algorithm. Laboratory staff received both clinical and technical training. Table 8: Laboratory staff trained for March 2016 Province No. of Labs Trained No. of Participants Eastern Cape 1 6 Northern Cape 2 8 Mpumalanga 1 14 8 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures

KZN (Advanced training) 30 30 Table 9: Health Care workers trained for March 2016 Province No. of Facilities Trained No. of Participants Limpopo 56 56 8. Challenges identified during the month of December None 9. Upcoming plans Roll out Roll out of Xpert MTB/RIF Ultra assay towards the end of 2016 Roll out of new software 4.7b for the GX16 and GX4 instruments. Continuous monitoring of sites through remote connectivity to improve program performance Development of the GeneXpert dashboard to improve program performance Recruitment of additional trainers to maximize service provided for NHLS labs and NDoH World TB Day event in Lephalale Limpopo 10. Publications None 9 Disclaimer: This is a dynamic specimen dataset requiring regular update and it should be noted that figures